Sio Gene Therapies Inc (SIOX) Return on Investment ROI from the third quarter of 2023 to third quarter of 2022 and for the year 2023, average high and low, overall ranking from Dec 31 2022 to Dec 31 2021 - CSIMarket
CSIMarket Company Name, Ticker, Competitors, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Sio Gene Therapies Inc   (NASDAQ: SIOX)


Sio Gene Therapies Inc's ROI from its third quarter of 2023 to the third quarter of 2022 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Sio Gene Therapies Inc's ROI in the third quarter of 2023?
Sio Gene Therapies Inc recorded a cumulative net loss of $-29 million during 12 months ending in the third quarter of 2023, resulting in a negative return on investment (ROI) of -55.06%.

Within the Healthcare sector 735 other companies had a higher return on investment. While return on investment, the total ranking has deteriorated compared to the second quarter of 2023 from 0 to 4892.

Definition and Formula of Return on Investment


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Investment (Dec 31 2022)
III. Quarter		 (Sep 30 2022)
II. Quarter		 (Jun 30 2022)
I. Quarter		 (Mar 31 2022)
IV. Quarter		 (Dec 31 2021)
III. Quarter
Y / Y Investment Change TTM -49.76 % -43.44 % -26.23 % 3.5 % 48.88 %
Y / Y Net Income Change TTM - - - - -
Investment (TTM) in Millions 45 49 53 62 78
Return On Investment (TTM) -55.06 % -82.92 % -93.15 % -81.07 % -59.38 %
SIOX's Overall Ranking # 4892 # 0 # 0 # 0 # 0
Seq. Investment Change TTM -13.63 % -17.47 % -17.17 % -14.92 % -2.76 %
Seq. Net Income Change TTM - - - - -
Net Income (TTM) in Millions -29 -50 -68 -72 -62

SIOX Company Profile >> Back to SIOX Roi Comparisons >> See Annual SIOX Return On Investment



Return On Investment SIOX's Ranking
Within: No.
Industry # 323
Sector # 736
Overall # 4892

Return On Investment Statistics
High Average Low
-35.86 %
-117.65 %
-208.61 %
(Jun 30 2021)   (Mar 31 2019)







Financial Statements
Sio Gene Therapies Inc's III. Quarter Investments $ 45 Millions SIOX's Balance sheet
Sio Gene Therapies Inc's III. Quarter Income $ -4 Millions Quarterly SIOX's Income Statement
SIOX's Income by Division See SIOX's Income by Division


SIOX Annual Return On Investment (Mar 31 2022)
2022		 (Mar 31 2021)
2021		 (Mar 31 2020)
2020		 (Mar 31 2019)
2019		 (Mar 31 2018)
2018
Total Investments in Millions 62 124 62 79 114
Y / Y Investment Growth -50.06 % 101.66 % -22.18 % -30.65 % -35.21 %
Net Income in Millions -72 -32 -73 -129 -222
Y / Y Net Income Growth - - - - -
Annual Return On Investment -115.8 % -26.09 % -117.83 % -162.95 % -194 %


Annual Roi Comment


Definition and Formula of Return on Investment

Other ROI Ratios
Major Pharmaceutical Preparations Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
SIOX's Roi Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for SIOX's Competitors
Subscribers only: Roi for Sio Gene Therapies Inc's Suppliers
Subscribers only: Return On Investment for SIOX's Customers

Other Ratios
SIOX's Roa SIOX's Inventory Turnover Ratio SIOX's Growth Rates SIOX's Dividend Statistics
SIOX's Profitability Ratios SIOX's Asset Turnover Ratio SIOX's Dividend Growth
SIOX's Roe SIOX's Valuation Ratios SIOX's Financial Strength Ratios SIOX's Dividend Payout Ratio



Companies with similar Return On Investment at Dec 31 2022, within Healthcare Sector ROI

Date modified: 2026-06-22T14:32:26+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.